Corridors - News for North Carolina Hospitals from the Health Care Attorneys of Poyner & Spruill LLP

March 2008


In This Issue

CMS Requires Certain Hospitals to Disclose Physician Financial Relationships Under Stark Law

Proposed Regulation Would Give Secretary of HHS Authority to Review and Reverse DAB Decisions in Provider Appeals from Final Agency Decisions

Honoring Military Service: FMLA Expansion Provides New Protections for the Families of Servicemembers

Changes Coming for 457 Deferred Compensation Plans

Important Websites

Poyner & Spruill Welcomes Jessica Lewis it our Health Care Team

 


CMS Requires Certain Hospitals to Disclose Physician Financial Relationships Under Stark Law

by Wilson Hayman

The Centers for Medicare & Medicaid Services (CMS) is conducting a mandatory review of physician investment and compensation arrangements at 500 hospitals to determine whether they are in compliance with the Stark law governing physician self-referrals. The selected hospitals are required to report information to CMS about physician investment, ownership and compensation arrangements on a new Disclosure of Financial Relationships Report (DFRR) within 60 days of the letter from CMS. A hospital’s late response can lead to civil monetary penalties of up to $10,000 per day. The accuracy of a hospital’s DFRR must be certified by the hospital’s CEO, CFO or comparable officer. This requirement should remind all Medicare-participating hospitals, whether or not they are required by CMS at this stage to submit a DFRR, of the need to track and ensure the legality of financial relationships with physicians.

Background

The Stark II law authorizes the Secretary of HHS to require hospitals and other entities furnishing more than 20 Medicare-reimbursed services during a calendar year to provide the Secretary or OIG with information concerning the hospital’s reportable financial relationships between a physician (or his or her immediate family member) and the entity. This information includes the covered services provided by the hospital and the names and unique physician identification numbers of all physicians with a financial interest in the entity. The term “financial interest” in this context includes ownership, investment or compensation arrangements. Although CMS indicated in the proposed Stark II regulations issued in January 1998 that it intended to require annual reports from hospitals of financial relationships with referring physicians, the final rules issued in 2004 merely required hospitals to furnish such information upon request.

The Deficit Reduction Act of 2005 required CMS to consider the issue of annual disclosure of information concerning physician ownership and investment interest in specialty hospitals. Consequently, CMS in 2006 sent a survey to approximately 450 specialty and general acute care hospitals to obtain a more complete picture of the proportionality of physician investment in specialty hospitals. Because CMS did not receive sufficient information from this voluntary survey, it has made the new DFRR mandatory and will use it to analyze investment and compensation arrangements for compliance with the Stark law and regulations. In this phase, CMS will target the 290 hospitals that did not respond to the 2006 survey, as well as 210 additional hospitals selected from across the country.

Although the DFRR was to be sent out to these 500 hospitals in September of 2007, a hospital’s failure to receive such a request last year does not protect it from scrutiny in the future. CMS has stated that it will use the information collected in this process to design a regular financial disclosure process applicable to all Medicare-participating hospitals in the future. While CMS estimated that completion of the DFRR will take approximately six hours by hospital accounting personnel, industry groups including the American Hospital Association cite this as extremely low and unrealistic in light of the large amount of information being requested.

Information Solicited by DFRR Through eight worksheets to be completed, the mandatory DFRR solicits a wide range of information. The first six worksheets pertain only to hospitals with physician ownership or investment and therefore apply only to specialty hospitals or other closely held entities with physician ownership. On the other hand, the two final worksheets apply to any hospital, including nonprofit, municipally owned or any other type of hospital with one or more compensation arrangements with physicians unless an exception applies. The required information includes the following:

  • The general characteristics of the hospital, including a copy of the hospital’s independently audited financial statements, if available, or other financial statements.

  • Any direct ownership interest in the hospital by any person, any indirect ownership by an entity, and the percentage of ownership interest and type of stock held. In the case of an investing entity, the form must also identify each investor or owner of the entity and the percentage of his or her ownership in the entity. Any individual investor, either a direct or indirect owner, must be identified as a physician or physician’s immediate family member if applicable. A separate worksheet must be completed for each physician owner or immediate family member with his or her Social Security number or Medicare National Provider Identifier (NPI) and certain other information.

  • Any payments made to the hospital by direct or indirect physician owners of the hospital, including without limitation initial investments, assessments, capital calls and loan guarantees, as well as the date, type and amount of payment. In cases of indirect ownership, the individuals who make up the investing entity must also be identified, as well as their status (such as a physician or an immediate family member). Any guarantee or other agreement that reduces or limits the physician’s risk of loss or liability must also be reported.

  • The following compensation arrangements between a hospital and physicians must be reported: all rentals of office space or equipment to or from the hospital and the physician; personal service arrangements; physician recruitment payments; a copy of each such agreement must be produced (but only one copy of a uniform personal services agreement needs to be supplied); isolated transactions such as a physician’s sale of property or practice; any compensation to a physician unrelated to a designated health service under Stark; any other payments by a physician to the hospital for items or services; charitable donations by a physician; nonmonetary compensation to physicians in the form of items or services exceeding $300 per physician per calendar year; incidental benefits valued at $25 or more per occurrence granted to medical staff members; any higher return paid on a physician’s invested capital than is warranted by the amount invested; loans or loan guarantees made by either the hospital or physician on behalf of the other; and any initial investments, capital calls or other payments made by the hospital on behalf of a physician.

  • Financial relationships permitted by Stark that apparently need not be reported on the DFRR are those relating to physician employment agreements, risk-sharing compensation agreements, compliance training, obstetrical malpractice insurance subsidies, professional courtesy, retention payments and community-wide health information systems.

The DFRR represents a significant change in CMS’s enforcement policy under the Stark law and increases the risk of scrutiny for both hospitals and physicians. It creates potentially new liabilities based on a hospital’s late submission of the DFRR and incomplete or inaccurate statements. If a hospital has not yet done so, it should examine all contracts or investment arrangements with physicians and evaluate its contract management systems to ensure compliance with Stark II requirements. If a hospital’s compliance plan does not already require collecting and reviewing this information through a legal audit of its physician agreements, then the hospital is strongly urged to do so in anticipation of CMS’s future adoption of an industry-wide mandatory disclosure program for hospitals.

Wilson Hayman may be reached at 919.783.1140 or whayman@poyners.com.

Top


Proposed Regulation Would Give Secretary of HHS Authority to Review and Reverse DAB Decisions in Provider Appeals from Final Agency Decisions

By Chris Brewer and Ken Burgess

A December 28, 2007, proposed regulation published in the Federal Register would drastically alter the current system of appeals from certain final agency decisions by allowing the Secretary of the U.S. Department of Health and Human Services (HHS) to review and reverse decisions issued by the federal Departmental Appeals Board (DAB). The impact of the proposed rule, if adopted, could be enormous for affected health care providers unhappy with the results of a final agency decision by removing one of the few due process safeguards available to providers that want to challenge decisions of the agency and the Centers for Medicaid & Medicare Services (CMS). The Proposed Rule seeks to impose uniform, sweeping changes to nearly all current Medicare administrative appeals processes under the DAB’s jurisdiction; however, the Proposed Rule would have different and far-reaching implications for each unique category of administrative appeal. Many national and state provider organizations have expressed opposition to the draft regulation.

Overview of Appeals System

The DAB provides impartial, independent review of disputed decisions in a wide range of Department programs under more than 60 statutory provisions. The DAB generally issues the final decision for the Department, which may then be appealed to federal court. The DAB resolves disputes with a wide variety of outside parties such as state agencies, Head Start grantees, universities, nursing homes, hospitals, doctors, and Medicare beneficiaries.

Disputes reviewed by the DAB include:

  • adjudicatory civil money penalties (CMPs) and exclusions imposed under a wide range of fraud and abuse authorities;

  • appeals in provider and supplier participation, enrollment and enforcement cases brought by the CMS;

  • final review of ALJ decisions under 42 C.F.R. Part 498 (e.g., initial determinations concerning participation in the Medicare and Medicaid programs, the imposition of sanctions on certain providers including skilled nursing facilities, the imposition of enforcement remedies on laboratories under both Medicare and the Clinical Laboratories Improvement Amendments of 1988);

  • appellate review authority concerning Medicare Local Coverage Determinations; original jurisdiction over National Coverage Determinations; and

  • the imposition of CMPs by CMS for violations of the HIPAA portability and health information privacy requirements.

Under the current system, providers that wish to challenge survey findings may file an appeal with the DAB, a division of HHS. The DAB consists of both the individual administrative law judges (ALJs) who initially hear provider appeals and appeals panels of three DAB members who sit as an appeals court of sorts to review ALJ decisions with which either the provider or CMS is unhappy. Following an initial decision by an ALJ, either the provider or CMS may appeal that decision to the DAB appellate panel. Currently, providers unhappy with a decision of the appeals panel may further appeal the decision to the U.S. District Court in their jurisdiction. CMS, however, does not have the power to appeal decisions of the DAB with which it disagrees.

As such, a decision of an ALJ which is not appealed to the DAB by either CMS or the provider becomes the final agency decision of HHS. If either the provider or CMS appeals the ALJ’s decision to the DAB, then the DAB decision becomes the final agency decision of HHS unless the provider further appeals to federal court. While the DAB is far from perfect, it is generally viewed as an unbiased quasi-judicial body that sometimes rules in favor of HHS and sometimes in favor of providers. Appeals before the DAB are difficult to win, but with the right set of facts and a well-prepared case, providers at least have a fighting chance to correct erroneous decisions by the agency and CMS.

Change Proposed

In the proposed regulation, the Secretary complains about two problems that the regulation would address: 1) currently the ALJs and DAB must follow applicable statutes and regulations governing appeals but are not expressly required to follow the Secretary’s published interpretations of those authorities or other “informal guidance” published by the Secretary; and 2) the Secretary currently has no authority to review decisions of the DAB with which he disagrees. The proposed regulation would address those issues by 1) requiring the ALJs and DAB to follow both applicable statutes and regulations and published interpretations of those authorities and other informal guidance published by the Secretary; and 2) allowing the Secretary to review and affirm, reverse or remand decisions of the ALJs or DAB with which he disagrees.

The rule affects all decisions on provider and supplier enrollment and certification, sanctions imposed by the Office of Inspector General in fraud and abuse matters, sanctions issued under the Clinical Laboratory Improvement Act, certain sanctions imposed under HIPAA, and nursing facility survey decisions, among others. The regulation, if adopted, would not affect final decisions already issued by the DAB, but would apply to any “pending litigation.” Thus, many provider appeals that are not fully decided would fall under the regulation and would be subject to review by the Secretary.

One of the more troubling aspects of the proposed regulation is the requirement for the DAB to follow the “published guidance” of the Secretary on the interpretation of applicable statutes and regulations, to the extent such guidance is not in conflict with the Department’s governing statutes and regulations. The proposed rule identifies “published guidance” as including any guidance that has been “publicly disseminated” by the Secretary, such as manual provisions, State Medicaid Agency Director Letters or information posted on the CMS website. Published guidance would not include statements included in briefs filed by CMS in appeal litigation, but the Secretary would require in the rule that the ALJs and DAB defer to arguments about the meaning of applicable statutes and regulations by giving weight to statements made by CMS counsel in provider appeal briefs, unless those statements conflict with published guidance of the Secretary or other agency statements of position. As applied to nursing facilities, for example, this would give CMS counsel defending a state survey agency decision an enormous advantage in survey appeals with providers by equating their litigation arguments with HHS policy, unless the provider could persuade the ALJ or DAB that such arguments conflict with guidance already issued by the Secretary.

Provider Concerns

The proposed rule would allow the Secretary to simply overrule ALJ or DAB decisions with which the Department disagrees by claiming those decisions are contrary to the Secretary’s interpretation of governing statutes and regulations. Appeals by health care providers are already difficult to win, given the paucity of due process protections for providers in the current system. This proposed regulation would essentially turn ALJ and DAB decisions from final agency decisions to “recommended” or “proposed” decisions subject to being overturned by the Secretary. The rule proposes no limits to the Secretary’s discretion in choosing when and how often to review and reverse or remand ALJ or DAB decisions. If the Secretary remands a decision to the ALJ or DAB, then the ALJ or DAB would be required to follow the Secretary’s statement of policy or interpretation of the law, and would simply be limited to applying the facts of the case according to the Secretary’s interpretation. It is not difficult to imagine the Secretary issuing ad hoc policy through his ability to reverse ALJ or DAB decisions with which he or his subordinate agency, CMS, simply disagrees.

The proposed regulation stresses that providers unhappy with the Secretary’s decision on an appeal could still appeal to federal court. Providers can already appeal to federal court, so that reassurance is little comfort to providers, particularly given that the vast majority of such appeals in federal court are decided in favor of the Secretary. This is largely due to the lack of understanding of the complex world of health care regulatory and compliance issues by federal judges and a policy inherent in federal law that gives great deference to the Secretary in complex technical matters. The Secretary suggests in the proposed regulation that his review authority would be used sparingly, but few providers or their attorneys take much comfort in this assertion. Most provider counsel believe the concerns expressed by the Secretary would be more appropriately addressed by affording the Secretary the same opportunity providers have had since adoption of appeals regulations for providers – the chance to appeal to federal court.

Under the proposed regulation, the Secretary would have authority to decide which final agency decisions to review and neither CMS nor the provider would have the right to request such review by the Secretary. Neither party would have the right to offer additional evidence or file briefs supporting its position with the Secretary, although the Secretary would in his discretion have the authority to request additional briefing. The Secretary would have 30 days following an ALJ or DAB decision to decide whether to review a decision, and an additional 45 days to render the Department’s final decision. However, that latter time period could be extended without limitation in the discretion of the Secretary.

Chris Brewer  may be reached at 919.783. 2891 or cbrewer@poynerspruill.com. Ken Burgess may be reached at 919.783.2917 or kburgess@poynerspruill.com.

Top


HR News


Honoring Military Service: FMLA Expansion Provides New Protections for the Families of Servicemembers

By Kevin Ceglowski

On January 28, 2008, President Bush signed the 2008 Defense Authorization Act (H.R. 4986), which became effective immediately and expanded the Family and Medical Leave Act (FMLA). This new law allows eligible employees to take FMLA leave for exigencies related to active duty military service or to care for family members injured while serving in the armed forces.

Servicemember Family Leave

The FMLA expansion provides new protections for employees in two areas. First, eligible employees may take up to 26 weeks of leave in a single 12-month period to care for family members injured during military service. A “spouse, son, daughter, parent, or next of kin” may take this leave to care for a member of the armed forces, including the National Guard or Reserves, suffering from a serious injury or illness. “Serious injury or illness” means an injury or illness incurred on active duty in the armed forces that may render the servicemember medically unfit to perform the duties of his or her office, grade, rank, or rating. Under the new law, when this “Servicemember Family Leave” is used, the total amount of FMLA leave taken in any 12-month period may not exceed 26 weeks.

Active Duty Leave

The FMLA expansion also provides a new basis for an employee to take 12 weeks of FMLA leave. An employee may take FMLA leave for “any qualifying exigency” arising out of the fact that the spouse, son, daughter, or parent of the employee is on active duty or has been notified of an impending call to active duty in the armed forces. The Department of Labor (DOL) has not yet issued regulations defining these qualifying exigencies. When the need for Active Duty Leave is foreseeable, the employee is required to provide the employer with reasonable and practicable notice.

Many provisions of the existing FMLA laws also apply to these new areas. Both the Servicemember Family Leave and Active Duty Leave may be taken intermittently or on a reduced leave schedule. As with other types of FMLA leave, an employer may require its employees to use available paid time off concurrently with FMLA leave. Employers may require a certification of need for Active Duty FMLA leave. The DOL has not yet defined what such a certification would consist of. An employer may also require a certification from a health care provider for Servicemember Family Leave.

Although the new FMLA law is effective immediately, the specific requirements for employers will not be clear until the DOL issues new regulations. In the meantime, employers should be aware of leave requests that might qualify as Active Duty Leave or Servicemember Family Leave.

If you have questions about whether a particular request qualifies, you should contact counsel for additional advice. If you have any questions about the new FMLA law and your company’s compliance with its provisions, or questions about the FMLA or employment law generally, please contact Kevin Ceglowski at kceglowski@poynerspruill.com or 919.783.2853 or Susie Gibbons at 919.783.2813 or sgibbons@poynerspruill.com.

 

Changes Coming for 457 Deferred Compensation Plans

By Gene Griggs

Many tax-exempt and governmental health care organizations use Code Section 457 deferred compensation plans as part of the financial package to attract and retain executives. Internal Revenue Service Notice 2007-62 announces the IRS’s intention to issue guidance that will require sponsors of 457 plans to evaluate and make changes to these plans. In general, the IRS guidance will apply the principles developed in the Code Section 409A regulations to similar provisions under Code Section 457.

The Notice indicates the upcoming guidance will focus on two areas that are central to the design of many health care organizations’ 457 plans: (1) the exemption from Code Section 457(f) for bona fide severance pay plans provided under Code Section 457(e)(11), and (2) the definition of “substantial risk of forfeiture” under Code Section 457(f)(3)(B). In fact, the Notice gives a preview of the new rules, which provides sponsors an opportunity to begin reviewing their plans and developing compliance strategies.

The IRS anticipates the new rules will provide that an arrangement will be an exempt bona fide severance pay plan only if all the following requirements are satisfied.

  1. The benefit is payable only upon involuntary severance from employment.

  2. The amount payable does not exceed two times the employee’s annual rate of pay, up to compensation limit under Code Section 401(a)(17) (the 2008 cap is $230,000, so $460,000 is the maximum).

  3. The arrangement provides payments must be completed by the end of the employee’s second tax year following the year in which the employee separates from service.

The guidance likely will include exceptions from the requirement that benefits be paid only upon involuntary severance from employment for window programs, collectively bargained separation pay plans, and certain reimbursement or in-kind benefit arrangements, similar to the exceptions provided under the Code Section 409A regulations.

The IRS further anticipates the new rules will provide that a number of popular features included in many 457(f) plans will no longer be considered as subjecting the benefits to a substantial risk of forfeiture. These features include:

  1. Covenants not to compete,

  2. Rolling vesting provisions by which the employer and employee mutually agree to delay the vesting date by written election of the employee one year or more before vesting otherwise would occur, and

  3. Employee deferral programs that defer receipt of salary on a tax-deferred and forfeitable basis.

These features are viewed by the IRS as contrary to the principles under the Code Section 409A regulations that compensation is subject to a substantial risk of forfeiture only if the entitlement to the amount is conditioned on the performance of future services or the occurrence of a condition that is related to the purpose of the compensation and the possibility of forfeiture is substantial. The IRS does not view merely refraining from the performance of services, the addition of a risk of forfeiture after the right to compensation arises, or the extension of a period during which compensation is subject to a risk of forfeiture as a valid or substantial risk of forfeiture.

These new rules are expected to apply on a prospective basis. Until further guidance is issued, taxpayers may rely on the definition of a bona fide severance pay plan and the rules regarding a substantial risk of forfeiture described in the Notice. Furthermore, the Notice provides that no inference should be made from the anticipated guidance described in the Notice on these matters regarding the current compliance status of plans under Code Section 457.

Gene Griggs is a member of our Employee Benefits Team. You may contact Gene at 704.342.5320 or ggriggs@poynerspruill.com.

Top


Important Websites

By Bill Shenton

 

Included in this web site segment are a few links to recent developments that came to our attention at press time.

 

CMS has issued a new document that gives health care organizations a heads-up on what to expect in a HIPAA Security Compliance Audit: http://www.cms.hhs.gov/Enforcement/Downloads/InformationRequestforComplianceReviews.pdf

The Office of Civil Rights has published a proposed rule pertaining to the confidentiality of patient safety data collected under the Patient Safety and Quality Improvement Act of 2005: http://a257.g.akamaitech.net/7/257/2422/01jan20081800/edocket.access.gpo.gov/2008/pdf/E8-2375.pdf

And for more information on the confidentiality of the data compiled by Patient Safety Organizations, go to: http://www.hhs.gov/ocr/psqia/

Office of Inspector General solicits comments on revisions to the Compliance Guidance for nursing facilities: http://oig.hhs.gov/08/CPG_Nursing_Facility_Solicitation.pdf

Institute of Medicine report on evidence-based medicine: http://www.rwjf.org/pr/product.jsp?id=25351&c=EMC-CA140

Bill Shenton is a member of our Health Care Team. You may contact Bill at 919.783.2947 or wshenton@poynerspruill.com.

 

Top


Poyner & Spruill Welcomes Jessica Lewis to the Health Care Team

 

Poyner & Spruill is pleased to announce the newest member of our Health Care Section, Jessica M. Lewis. Jessica is a lawyer, a registered nurse and a former captain in the U.S. Army.

She joins us from the law firm of Young Moore and Henderson, where she concentrated her practice on medical malpractice defense litigation and health law. At Poyner & Spruill, she will work on a broad range of cases and issues for our health care clients.

Jessica earned her Bachelor of Science degree in Nursing from the University of North Carolina at Chapel Hill in May 1998. Upon graduation, she received a commission in the United States Army. From 1998 to 2002, she served on active duty as a medical-surgical and surgical critical care nurse in the Army Nurse Corps, rising to the rank of captain. Jessica received her law degree from the University of North Carolina at Chapel Hill in 2005.

Jessica enjoys traveling, having grown up in a number of different places, including Izmir, Turkey, as a self-described “army brat.” According to Jessica, she also attempts to enjoy running. We are extremely excited to have this bright and accomplished young attorney join our growing health care practice, and we know you’ll enjoy working with her. Jessica may be reached at jlewis@poynerspruill.com or 919.783.2941.

 

Top

 

 

Home | Attorneys  | Practice Areas | Publications | About Us | What's New | Careers | Search | Offices 

Poyner & Spruill LLP has offices in CharlotteRaleigh, Rocky Mount and Southern Pines

Physical Address:  3600 Glenwood Avenue, Raleigh, NC 27612

© Poyner Spruill
Site by
Consultwebs.com, Specializing In Webs For Law Firms